Endocrine Abstracts

Primary aldosteronism (PA) is the most frequent cause of endocrine arterial hypertension. PA is known to cause a higher cardiovascular morbidity, which is reduced by specific therapy of PA. Numerous studies suggest that mineralocorticoid excess may influence mineral homeostasis. On the other side, parathyroid hormone excess has been linked to cardiovascular disease. Increasing evidence supports a bidirectional interaction between aldosterone and PTH which might lead to a highe...

Primary aldosteronism (PA) describes the most frequent cause of secondary arterial hypertension. Aldosterone itself represents a BP-independent cardiovascular risk factor associated with increased rates of morbidity and mortality. Recently a worsening of lipid metabolism after treatment has been described.Objective: Our aim was to analyse changes in lipid parameters according to treatment outcome in PA patients. Data of 215 consecutive PA patients with u...